Shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Rating) have been assigned a consensus recommendation of “Hold” from the twenty-three ratings firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, five have given a hold rating and seven have issued a buy rating on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $46.50.
A number of brokerages have issued reports on BBWI. JPMorgan Chase & Co. cut their price target on shares of Bath & Body Works from $48.00 to $38.00 in a research note on Monday, May 8th. Credit Suisse Group upped their target price on shares of Bath & Body Works from $42.00 to $46.00 and gave the stock a “neutral” rating in a research note on Friday, February 24th. Morgan Stanley decreased their price target on shares of Bath & Body Works from $76.00 to $61.00 in a research report on Friday, May 19th. Telsey Advisory Group reaffirmed an “outperform” rating and set a $52.00 price objective on shares of Bath & Body Works in a research report on Thursday, February 23rd. Finally, UBS Group lowered Bath & Body Works from a “buy” rating to a “neutral” rating in a report on Wednesday, March 29th.
Insider Activity at Bath & Body Works
In other Bath & Body Works news, CFO Wendy C. Arlin sold 1,625 shares of the firm’s stock in a transaction dated Tuesday, March 28th. The stock was sold at an average price of $38.29, for a total transaction of $62,221.25. Following the transaction, the chief financial officer now owns 91,072 shares of the company’s stock, valued at $3,487,146.88. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.19% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Bath & Body Works
Bath & Body Works Stock Performance
NYSE:BBWI opened at $38.51 on Wednesday. Bath & Body Works has a fifty-two week low of $25.75 and a fifty-two week high of $49.55. The company has a 50 day moving average price of $35.30 and a 200 day moving average price of $39.56. The stock has a market capitalization of $8.81 billion, a P/E ratio of 12.19, a PEG ratio of 1.02 and a beta of 1.70.
Bath & Body Works (NYSE:BBWI – Get Rating) last released its quarterly earnings results on Thursday, May 18th. The company reported $0.33 EPS for the quarter, topping analysts’ consensus estimates of $0.26 by $0.07. The company had revenue of $1.40 billion for the quarter, compared to analysts’ expectations of $1.39 billion. Bath & Body Works had a negative return on equity of 29.65% and a net margin of 9.67%. The firm’s revenue was down 3.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.64 earnings per share. Research analysts forecast that Bath & Body Works will post 2.93 earnings per share for the current fiscal year.
Bath & Body Works Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, June 16th. Investors of record on Friday, June 2nd will be given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.08%. The ex-dividend date is Thursday, June 1st. Bath & Body Works’s dividend payout ratio (DPR) is 25.32%.
Bath & Body Works Company Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
- Get a free copy of the StockNews.com research report on Bath & Body Works (BBWI)
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.